Cyclin-Dependent Kinase Inhibitor–Associated Thromboembolism

This Viewpoint analyzes data on the thrombotic risk associated with cyclin-dependent kinase inhibitors and notes the need for additional research on the thrombotic risk of these drugs, the influence of combined drug therapy on thrombotic risk, and patient selection.

https://ift.tt/2Bd8MmM